In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

IPO nets $50.2mm for Complete Genomics

27 Apr 2012

Executive Summary

Four months after its S-1 filing, large-scale human genome sequencing start-up Complete Genomics Inc. netted $50.2mm in an IPO of 6mm common shares at $9. The company announced last month that it had hoped to get between $12-14 per share.
Deal Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Services
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By